<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/><meta name="exporter-version" content="Evernote Mac 7.14 (458244)"/><meta name="author" content="taylor.arhar@gmail.com"/><meta name="created" content="2017-08-17 17:25:52 +0000"/><meta name="source" content="desktop.mac"/><meta name="updated" content="2017-08-18 01:18:47 +0000"/><title>August 17, 2017</title></head><body><div>Transfer fibrils to non-binding tubes:</div><div>- all samples were combined in 50 mL falcon tubes and then transferred to nonbinding tubes in approx 1.5 mL aliquots</div><div>- for one tube of each of the following samples, the original tube was refilled with 330 uL of PBS to test for tube binding: WT, K18, K18 P301L, and K18 P301L no heparin control</div><div><br/></div><div>Day 2 western blots:</div><div>- collected primary Ab and stored in cold room</div><div>- rinsed off primary with TBST for 30 min on rocker at RT</div><div>- added secondary at a 1:10,000 dilution in 5% milk in TBST and incubated on rocker at RT for 45 min</div><div>- imaged with ECL Prime reagent, exposing for up to 7 minutes</div><div>- RESULTS: was able to get a pretty good signal for all blots; tubulin and GFP blots had relatively expected ratios (WT has most GFP in microtubule fraction, followed by N279K and then by P301L—however more GFP in N279K cytoplasmic fraction than expected); tau blot had unexpected P301L ratio (MUCH more tau in the microtubule fraction than cytosolic fraction—opposite of expected result), which may be due to switching the sample order—&gt;will strip GFP blot and reblot for tau to confirm results</div><div><br/></div><div>Quantify fresh fibril batch:</div><div>- FL tau gel lanes: </div><div>1. ladder </div><div>2. 0.6 mg/mL </div><div>3. 0.5 mg/mL </div><div>4. 0.4 mg/mL </div><div>5. 0.3 mg/mL </div><div>6. 0.2 mg/mL </div><div>7. 5 uL WT fibril </div><div>8. 5 uL P301L fibril </div><div>9. 5 uL N279K fibril </div><div>10. 5 uL 12 hr WT aliquot </div><div>11. 10 uL PBS-refilled aggregation tube </div><div>12-15. loading control</div><div>- K18 gel lanes: </div><div>1. ladder </div><div>2. 0.4 mg/mL </div><div>3. 0.2 mg/mL </div><div>4. 0.075 mg/mL </div><div>5. 0.025 mg/mL </div><div>6. 0.0125 mg/mL </div><div>7. 10 uL K18 fibril </div><div>8. 10 uL K18 P301L fibril </div><div>9. 10 uL K18 P301L no heparin control </div><div>10. 10 uL K18 12 hr aliquot </div><div>11. 10 uL K18 P301L 12 hr aliquot </div><div>12. 10 uL K18 P301L no heparin control 12 hr aliquot </div><div>13. 10 uL K18 PBS-refilled aggregation tube </div><div>14. 10 uL K18 P301L PBS-refilled aggregation tube </div><div>15. 10 uL K18 P301L no heparin control PBS-refilled aggregation tube</div><div>- RESULTS: FL tau fibrils seem to all fall within expected standard range; K18 fibrils are concentrated, maybe more concentrated than 0.4 mg/mL (by visual assessment); by visual assessment, it seems that much more K18 P301L is getting stuck in the aggregation tube than the other variants, or the no heparin control</div><div><br/></div><div/><div><img src="August%2017,%202017.html.resources/IMG_0250.JPG" /><br/></div><div><br/></div></body></html>
